- Original Article
- A Clinical Observation of Neonatal Hyperbilirubinemia Due to ABO imcompatibility
-
Kang Woo Lee, Young Guk Kim, Dong Gun Park, Kee Hwan Yoo, Kwang Chul Lee, Soon Kyum Kim
-
Clin Exp Pediatr. 1994;37(1):54-60. Published online January 15, 1994
-
|
|
A clinical and statistical study was performed on 213 neonates of hyperbilirubinemia who were admitted to department of pediatrics of Korea University Hospital from Jan. 1989 to Jun. 1991. And we studied the difference between ABO compatible group and incompatible group, such as, day of appe5rance of hyperbilirubinemia, tendency of bilirubin concentration change, reticulocyte, hemoglobin and duration of hyperbilirubinemia.
The following... |
-
-
- A Clinical Survey of Prolonged Q-T Syndrome among Korean Children with Congenital Deafness
-
Kang Woo Lee, Kyung Bum Kim, Chang Sung Son, Joo Won Lee, Young Chang Tockgo
-
Clin Exp Pediatr. 1993;36(9):1236-1244. Published online September 15, 1993
-
|
|
The clinical symptom complex characterized by syncopal attacks and sudden death in patients with electrocardiographic anomalies, especially a prolonged Q-t interval is known as the Romano-Ward syndrome. When a similar syptom complex is accompanied by congenital deafness, it is called Jervell and Lange-Nieisen syndrome. This study was underataken to investigate the incidence of the latter syndrome in the... |
-
-
- Plasma Immunoreactive Endothlin-1, Creatine Kinase and CK Isoenzyme and Its Relation to Neonate with-Asphyxia
-
Kang Woo Lee, Kee Hyoung Lee, Chang Sung Son, Young Chang Tockgo
-
Clin Exp Pediatr. 1993;36(10):1434-1440. Published online October 15, 1993
-
|
|
Endotheline-1(ET-1) is a potent vasoconstrictor peptide with 21 amino acid residues.
ET-1 is thought to have a key role in vasoconstriction, and cardiac, renal, and endocrine actions of the peptide.
Creatine Kinase(CK), also referred to as ATP-creatine-N-phosphotransferase, consists of either the B or M type. CK is found almost exclusively in muscle (MM), myocardium (MB), and brain (BB). It is... |
-
-
|
